Zobrazeno 1 - 10
of 45
pro vyhledávání: '"John Patin"'
Autor:
John M. Bennett, Craig B. Reeder, Gordon W. Dewald, A. Giagounidis, Kenton Wride, Deborah A. Thomas, Michele Schmidt, Bayard L. Powell, Eric J. Feldman, Robert Knight, John Patin, Richard Stone, Peter L. Greenberg, Alan F. List, Jerome B. Zeldis, Azra Raza
Publikováno v:
New England Journal of Medicine. 355:1456-1465
Severe, often refractory anemia is characteristic of the myelodysplastic syndrome associated with chromosome 5q31 deletion. We investigated whether lenalidomide (CC5013) could reduce the transfusion requirement and suppress the abnormal 5q31- clone i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae0b57723da52d01b3c0a031e3405223
https://doi.org/10.1056/nejmoa061292
https://doi.org/10.1056/nejmoa061292
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 43:1415-1421
Objective: To evaluate clinical measures of the benefit/risk ratio in a post hoc analysis of a clinical trial of d - threo -methylphenidate hydrochloride ( d -MPH) and d,l - threo -methylphenidate hydrochloride ( d , l -MPH). Method: Data from a phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c36bf2323f28a31091881c4aba88eaeb
https://doi.org/10.1097/01.chi.0000138352.06229.b0
https://doi.org/10.1097/01.chi.0000138352.06229.b0
Autor:
Joan Bosch, John Patin, Andrea Freeman, Faith E. Davies, Raman Desikan, Jerome B. Zeldis, Emily A. Blood, Robert Knight, Paul G. Richardson, Deborah Doss, Melissa Alsina, Robert L. Schlossman, Sundar Jagannath, Teru Hideshima, Kenneth C. Anderson, William S. Dalton, Constantine S. Mitsiades, Edie Weller
Publikováno v:
Mayo Clinic Proceedings. 79:875-882
OBJECTIVE To determine the progression-free survival at 12 weeks, to evaluate the toxic effects, and to analyze the biological activity of thalidomide in patients with relapsed multiple myeloma (MM) after high-dose chemotherapy and stem cell transpla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c06e09122cdbfacd3462cc8ccda9f1c7
https://doi.org/10.4065/79.7.875
https://doi.org/10.4065/79.7.875
Autor:
Andrew Belch, Sagar Lonial, Christine Chen, Jerome B. Zeldis, Michael Wang, Ivan Borrello, Zhinuan Yu, Ruben Niesvizky, Donna M. Weber, David S. Siegel, Marta Olesnyckyj, Robert Knight, Asher A. Chanan-Khan, John Patin, Edward A. Stadtmauer, S. Vincent Rajkumar
Publikováno v:
The New England journal of medicine. 357(21)
Lenalidomide, an oral immunomodulatory drug that is similar to thalidomide but has a different safety profile, has clinical activity in relapsed or refractory multiple myeloma.Patients in the United States and Canada who had received at least one pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b78c4dbb9deab55c1a71f924ddfe99df
https://pubmed.ncbi.nlm.nih.gov/18477992
https://pubmed.ncbi.nlm.nih.gov/18477992
Autor:
Meletios, Dimopoulos, Andrew, Spencer, Michael, Attal, Miles Prince, H., Jean Luc Harousseau, Anna, Dmoszynska, San Miguel, J., Andrzej, Hellmann, Thierry, Facon, Foa, Roberto, Alessandro, Corso, Zvenyslava, Masliak, Marta, Olesnyckyj, Zhinuan, Yu, John, Patin, Zeldis, Jerome B., Knight, Robert D., Multiple Myeloma Study Investigators
Lenalidomide is a structural analogue of thalidomide with similar but more potent biologic activity. This phase 3, placebo-controlled trial investigated the efficacy of lenalidomide plus dexamethasone in the treatment of relapsed or refractory multip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36610e232f502a0cc6d7943565788fdd
http://hdl.handle.net/11573/35194
http://hdl.handle.net/11573/35194
Autor:
Raul R. Silva, John Patin, Harvey A. Tilker, Vikram Khetani, John T. Cecil, Sharon C. Kowalik, Herbert Faleck
Publikováno v:
Journal of child and adolescent psychopharmacology. 14(4)
This pilot study examined the efficacy and duration of the effect of dexmethylphenidate (d-MPH) given once-daily in subjects with attention deficit hyperactivity disorder (ADHD).Subjects aged 6-18 years (inclusive) with ADHD were enrolled in this 8-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb4b0e1e00ec2508f063fcc9da802f1a
https://pubmed.ncbi.nlm.nih.gov/15662147
https://pubmed.ncbi.nlm.nih.gov/15662147